Repurposing Generic Drugs

Doctor explaining medication and health information to a patient during a medical consultation

About the Project

The next major medical breakthroughs could come from long-approved, affordable drugs already on pharmacy shelves. Many medicines have multiple benefits, like aspirin, which was shown to help prevent heart attacks decades after it was first used as a pain reliever. However, once a drug’s patents expire, companies have little reason to invest in the costly studies needed to discover new uses. As a result, society has lost out on, perhaps, hundreds of new therapies.

The Market Shaping Accelerator (MSA) is working to change this. By designing funding models that reward successful generic drug repurposing efforts, MSA helps governments and foundations create incentives that spur researchers to explore overlooked drugs and develop them into effective new treatments.

Featured Work

Contact

Sarrin Chethik (schethik@marketshapingaccelerator.org), Senior Policy Analyst, Market Shaping Accelerator
Hassan Sayed (hsayed@marketshapingaccelerator.org), Postdoctoral Scholar, Market Shaping Accelerator

Experts

Sarrin Chethik

Sarrin is a Senior Policy Analyst at the Market Shaping Accelerator. He works on health and climate projects, including repurposing generic drugs, vaccines for pandemics, and climate-resilient crops.

Leah Rosenzweig

Leah R. Rosenzweig is a senior fellow at the Center for Global Development and Director of the Market Shaping Accelerator (MSA). Leah’s research focuses on understanding the underlying factors that shape political and social behavior, with an interest in how these factors influence macro-level policy outcomes.

Hassan Sayed

Hassan Sayed

Hassan is a postdoctoral scholar at the Market Shaping Accelerator (MSA). His research studies the informational externalities of policymaking with applications to topics in applied theory and political economy.

Christopher Snyder

Christopher Snyder is the Hyatt Professor in the Economics Department at Dartmouth College. His research and policy interests focus on incentivizing commercial markets to innovate to address global social problems such as pandemic preparedness and global warming.